Comments
Ajanta Pharma has launched generic omeprazole and sodium bicarbonate capsules used in the treatment of acid reflux and ulcers in the US market after receiving final approval from the country’s health regulator.
The company has launched the product in the US through its wholly-owned subsidiary, Ajanta Pharma USA Inc, Ajanta Pharma said in a filing to the BSE.
Approval from the United States Food and Drug Administration (USFDA) is for the capsules in the strengths of 20mg/1100 mg and 40 mg/1100 mg, it added.
The capsules are generic version of Santarus Inc’s Zegerid capsules.
The company has 26 abbreviated new drug applications (ANDAs) of which it has received final approvals for 11, tentative nod for 1 ANDA, while 14 are under review with the USFDA, it added.
Shares of Ajanta Pharma were trading down by 0.13 per cent at Rs 1,596 on the BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.